Vermont · 64643

Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, Each Additional Extremity in Vermont

Vermont Medicare Avg
$51.22
20% below national avg
National Medicare Avg
$64.26
All states combined
Billed Charge (VT)
$181.50
What providers submit
Est. Commercial (VT)
$147.92
National avg: $185.18
Est. Cash / Self-Pay (VT)
$100.34
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

85
Services in VT
11
Providers
N/A
Min Payment
N/A
Max Payment

Vermont Pricing in Context

In Vermont, CPT code 64643 (Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, Each Additional Extremity) carries an average Medicare payment of $51.22 — 20% below the national benchmark of $64.26. 11 providers across the state submitted claims for this procedure in 2023, performing 85 total services. Individual payments in VT ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Vermont is $181.50, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Vermont sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Nervous System Surgery procedures, the estimated commercial insurance price in Vermont lands near $147.92, with self-pay cash prices typically around $100.34. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, Each Additional Extremity cost in Vermont?

The average Medicare payment for Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, Each Additional Extremity in Vermont is $51.22, which is 20% below the national average of $64.26. Providers in VT typically bill $181.50 for this procedure.

What does Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, Each Additional Extremity cost with insurance in Vermont?

With commercial insurance in Vermont, Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, Each Additional Extremity costs an estimated $147.92. Without insurance, the estimated cash price is $100.34. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, Each Additional Extremity in Vermont?

11 providers in Vermont billed Medicare for Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, Each Additional Extremity in 2023, performing 85 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, Each Additional Extremity cheaper in Vermont than the national average?

Yes — Injection Of Chemical For Paralysis Of Nerve Muscles On Arm Or Leg, 1-4 Muscles, Each Additional Extremity costs 20% below the national average in Vermont. The state average Medicare payment is $51.22 compared to $64.26 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial